Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
25.11
-0.05 (-0.20%)
At close: Aug 14, 2025, 3:59 PM
25.20
0.38%
Pre-market: Aug 15, 2025, 08:44 AM EDT
Pfizer Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2019 |
|---|---|---|---|---|---|
| Biopharma Segment Revenue | 62.4B | 57.19B | 98.99B | 79.56B | 39.42B |
| Biopharma Segment Revenue Growth | +9.12% | -42.23% | +24.42% | +101.82% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Developed Rest Of World Revenue | 16.06B | 7.76B | 15.78B | 12.51B | 4.04B | 6.46B | 6.55B | 6.61B | 6.73B | 6.3B | 7.31B | 8.35B | 10.55B | 11.09B | 10.09B |
| Developed Rest Of World Revenue Growth | +106.89% | -50.81% | +26.16% | +209.86% | -37.57% | -1.31% | -0.92% | -1.74% | +6.84% | -13.89% | -12.37% | -20.92% | -4.84% | +9.91% | n/a |
| Emerging Markets Revenue | 8.88B | 12B | 20.1B | 20.7B | 8.37B | 12.73B | 12.65B | 11.4B | 10.42B | 11.14B | 11.5B | 11.22B | 11.97B | 13.1B | 12.01B |
| Emerging Markets Revenue Growth | -25.98% | -40.31% | -2.92% | +147.26% | -34.25% | +0.65% | +10.98% | +9.40% | -6.43% | -3.16% | +2.44% | -6.23% | -8.65% | +9.14% | n/a |
| United States Revenue | 38.69B | 27.09B | 42.47B | 29.75B | 21.71B | 23.85B | 25.33B | 26.03B | 26.37B | 21.7B | 19.07B | 20.27B | 23.09B | 26.93B | 29.05B |
| United States Revenue Growth | +42.83% | -36.22% | +42.79% | +37.00% | -8.97% | -5.83% | -2.68% | -1.30% | +21.49% | +13.79% | -5.92% | -12.18% | -14.28% | -7.27% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 29, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Dec 31, 2021 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Dec 31, 2016 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Dec 31, 2015 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.4B | 3.02B | 4.23B | 3.24B | 3.69B | 3.46B | 4.47B | 3.21B | 3.43B | 3.36B | 4.43B | 3.25B | 2.91B | 2.52B | 3.96B | 2.75B | 2.83B | 2.71B | 3.67B | 2.62B | 2.6B | 2.53B | 4.21B | 3.24B | 3.49B | 3.33B | 3.99B | 3.48B | 3.53B | 3.4B | 4.53B | 3.48B | 3.42B | 3.3B | 4.4B | 3.54B | 3.47B | 3.38B | 5.05B | 3.27B | 3.39B | 3.1B |
| Selling, General, and Administrative Revenue Growth | +12.50% | -28.44% | +30.51% | -12.20% | +6.62% | -22.62% | +39.17% | -6.41% | +2.23% | -24.17% | +36.05% | +11.67% | +15.68% | -36.47% | +44.23% | -2.76% | +4.20% | -26.08% | +39.97% | +1.00% | +2.77% | -40.06% | +30.18% | -7.36% | +4.96% | -16.48% | +14.64% | -1.39% | +3.86% | -25.06% | +30.25% | +1.84% | +3.52% | -24.99% | +24.38% | +1.87% | +2.54% | -32.94% | +54.37% | -3.43% | +9.09% | n/a |
| Research and Development Revenue | 2.44B | 2.18B | 3.02B | 2.56B | 2.68B | 2.48B | 2.77B | 2.68B | 2.63B | 2.49B | 3.62B | 2.7B | 2.81B | 2.3B | 5.92B | 2.68B | 2.24B | 1.99B | 3.35B | 2.3B | 2.08B | 1.68B | 2.81B | 2.28B | 1.83B | 1.7B | 2.44B | 2B | 1.79B | 1.74B | 2.3B | 1.85B | 1.78B | 1.7B | 2.5B | 1.87B | 1.75B | 1.73B | 2.35B | 1.72B | 1.73B | 1.89B |
| Research and Development Revenue Growth | +12.12% | -27.78% | +17.62% | -4.15% | +7.90% | -10.57% | +3.39% | +2.02% | +5.41% | -31.01% | +34.09% | -4.23% | +22.34% | -61.10% | +120.63% | +19.74% | +12.29% | -40.51% | +45.80% | +10.80% | +23.73% | -40.41% | +23.42% | +24.52% | +7.96% | -30.49% | +22.06% | +11.68% | +3.05% | -24.61% | +24.54% | +4.17% | +4.41% | -32.01% | +33.65% | +7.09% | +0.98% | -26.28% | +36.35% | -0.69% | -8.01% | n/a |